menu
{ "item_title" : "Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development", "item_author" : [" Institute of Medicine", "Board on Health Sciences Policy", "Forum on Drug Discovery Development and "], "item_description" : "The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop.", "item_img_path" : "https://covers4.booksamillion.com/covers/bam/0/30/922/214/0309222141_b.jpg", "price_data" : { "retail_price" : "31.00", "online_price" : "31.00", "our_price" : "31.00", "club_price" : "31.00", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development|Institute of Medicine

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development : Workshop Summary

local_shippingShip to Me
On Order. Usually ships in 2-4 weeks
FREE Shipping for Club Members help

Overview

The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop.

This item is Non-Returnable

    1

Details

  • ISBN-13: 9780309222143
  • ISBN-10: 0309222141
  • Publisher: National Academies Press
  • Publish Date: May 2012
  • Page Count: 118

Related Categories

BAM Customer Reviews